Wilson R F, Christensen B V, Olivari M T, Simon A, White C W, Laxson D D
Department of Medicine, University of Minnesota, Minneapolis.
Circulation. 1991 Apr;83(4):1210-20. doi: 10.1161/01.cir.83.4.1210.
Cardiac transplantation (CT) causes total cardiac denervation.
To test directly for sympathetic reinnervation in humans, we measured the cardiac release of norepinephrine (NE) in response to tyramine (an agent that causes NE release from intact sympathetic nerve terminals) and sustained handgrip exercise (a reflex sympathetic stimulus) in 12 patients less than 5 months after CT, in 50 patients 1 year or more after CT, and in eight patients without CT. Plasma [NE] was measured in the aorta [( NE]Ao) and coronary sinus [( NE]CS) at rest, after tyramine administration (55 micrograms/kg, i.v.), and during sustained handgrip exercise. Cardiac NE release was determined by subtracting [NE]Ao from [NE]CS [( NE]CS-Ao). NE release was defined as [NE]CS-Ao during the intervention-[NE]CS-Ao at rest (delta [NE]CS-Ao). In patients studied within 5 months of CT, no significant NE release occurred after tyramine administration (delta [NE]CS-Ao, 33 +/- 18 pg/ml; range, -98 to 117 pg/ml) or handgrip exercise (delta [NE]CS-Ao, -34 +/- 10 pg/ml; range, -46 to 8 pg/ml; n = 10). Conversely, in 39 of 50 patients studied 1 year or more after CT, tyramine administration caused a significant cardiac NE release (delta [NE]CS-Ao, 500 +/- 59 pg/ml; range, -11 to 1,918 pg/ml), and handgrip exercise caused a significant NE release in 17 of 41 patients (delta [NE]CS-Ao, 189 +/- 34 pg/ml; range, -211 to 949 pg/ml). In normally innervated patients, tyramine caused an even larger NE release (delta [NE]Ao-CS, 1,943 +/- 210 pg/ml; range, 1,152 to 2,977 pg/ml), and handgrip exercise caused a significant NE release in two of seven patients (delta [NE]CS-Ao, 143 +/- 51 pg/ml; range, -15 to 338 pg/ml).
Early after CT, neither tyramine nor handgrip exercise caused a significant cardiac release of NE, suggesting sympathetic denervation. Late after CT, most patients had a significant, but subnormal, NE release in response to pharmacological or reflex stimuli, suggesting that limited sympathetic reinnervation occurs in most patients after orthotopic CT.
心脏移植(CT)导致心脏完全去神经支配。
为直接检测人类交感神经再支配情况,我们在12例CT术后不到5个月的患者、50例CT术后1年或更长时间的患者以及8例未接受CT的患者中,测量了去甲肾上腺素(NE)对酪胺(一种促使NE从完整交感神经末梢释放的药物)的心脏释放量以及持续握力运动(一种反射性交感神经刺激)后的心脏释放量。在静息状态、给予酪胺(55微克/千克,静脉注射)后以及持续握力运动期间,测量主动脉血浆[NE]([NE]Ao)和冠状窦血浆[NE]([NE]CS)。心脏NE释放量通过[NE]CS减去[NE]Ao([NE]CS - Ao)来确定。NE释放定义为干预期间的[NE]CS - Ao减去静息时的[NE]CS - Ao(Δ[NE]CS - Ao)。在CT术后5个月内接受研究的患者中,给予酪胺后未发生显著的NE释放(Δ[NE]CS - Ao,33±18皮克/毫升;范围, - 98至117皮克/毫升),握力运动后也未发生显著NE释放(Δ[NE]CS - Ao, - 34±10皮克/毫升;范围, - 46至8皮克/毫升;n = 10)。相反,在50例CT术后1年或更长时间接受研究的患者中,39例给予酪胺后引起了显著的心脏NE释放(Δ[NE]CS - Ao,500±59皮克/毫升;范围, - 11至1918皮克/毫升),41例患者中有17例在握力运动后引起了显著的NE释放(Δ[NE]CS - Ao,189±34皮克/毫升;范围, - 211至949皮克/毫升)。在神经支配正常的患者中,酪胺引起了更大的NE释放(Δ[NE]Ao - CS,1943±210皮克/毫升;范围,1152至2977皮克/毫升),7例患者中有2例在握力运动后引起了显著的NE释放(Δ[NE]CS - Ao,143±51皮克/毫升;范围, - 15至338皮克/毫升)。
CT术后早期,酪胺和握力运动均未引起显著的心脏NE释放,提示交感神经去神经支配。CT术后晚期,大多数患者对药物或反射性刺激有显著但低于正常的NE释放,提示在原位心脏移植术后大多数患者发生了有限的交感神经再支配。